Genelux (GNLX) EBITDA Margin (2022 - 2024)
Genelux has reported EBITDA Margin over the past 3 years, most recently at 101437.5% for Q1 2024.
- Quarterly results put EBITDA Margin at 101437.5% for Q1 2024, down 9763632.0% from a year ago — trailing twelve months through Dec 2024 was 375812.5% (down 36159779.0% YoY), and the annual figure for FY2025 was 402500.0%, down 2976250.0%.
- EBITDA Margin for Q1 2024 was 101437.5% at Genelux, down from 3801.18% in the prior quarter.
- Over the last five years, EBITDA Margin for GNLX hit a ceiling of 57.67% in Q3 2022 and a floor of 101437.5% in Q1 2024.
- Median EBITDA Margin over the past 3 years was 4175.59% (2023), compared with a mean of 27432.75%.
- Peak annual rise in EBITDA Margin hit -9763632bps in 2024, while the deepest fall reached -9763632bps in 2024.
- Genelux's EBITDA Margin stood at 4550.0% in 2022, then rose by 16bps to 3801.18% in 2023, then plummeted by -2569bps to 101437.5% in 2024.
- The last three reported values for EBITDA Margin were 101437.5% (Q1 2024), 3801.18% (Q1 2023), and 4550.0% (Q4 2022) per Business Quant data.